BioTelemetry, Inc. Names Manish Wadhwa, M.D., F.H.R.S. Chief Medical Officer
August 05 2019 - 12:07PM
BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical
technology company focused on the delivery of health information to
improve quality of life and reduce cost of care, announced today
that Manish Wadhwa, M.D., F.H.R.S. (Fellow of the Heart Rhythm
Society), has been named Chief Medical Officer. Dr. Wadhwa will
lead the company’s clinical strategy and operations, reporting to
Joseph H. Capper, President and Chief Executive Officer.
Dr. Wadhwa, co-founder of Geneva Health
Solutions, joined BioTelemetry in March 2019 as part of the
company’s acquisition of Geneva. He is an actively practicing,
board-certified cardiologist and cardiac electrophysiologist,
serving the San Diego community in private practice since 2000. Dr.
Wadhwa brings over 26 years of clinical experience with expertise
in both implanted device management and follow-up as well as
invasive and non-invasive treatments of arrhythmias.
“Dr. Wadhwa’s energy, passion and expertise will
be valuable as we work to enhance our current product and service
offerings and create new ways to improve the health and well-being
of our patients and communities,” said Joseph H. Capper, President
and Chief Executive Officer of BioTelemetry. “He is an experienced
electrophysiologist with a distinguished career as a clinician and
executive, and he will play a key role in our advancement of
innovative and affordable connected health solutions across our
family of companies.”
Dr. Wadhwa received his undergraduate training
at Penn State University and his M.D. degree from Thomas Jefferson
University in Philadelphia, PA, where he trained in internal
medicine and general cardiology. He completed his cardiology
training with two years of advanced fellowship in cardiac
electrophysiology at the University of California San Diego. He has
served on the physician advisory boards of Medtronic, Boston
Scientific, Biotronik, St. Jude Medical and Sanofi-Aventis, and is
a fellow of the Heart Rhythm Society. Dr. Wadhwa has authored
numerous medical papers, lectures on clinical issues in cardiac
electrophysiology and continues to be involved with post-market
evaluations of commercially available implanted device leads and
generators.
“BioTelemetry has created tremendous momentum in
the connected health space and is uniquely positioned to deliver
meaningful solutions that address today’s healthcare challenges,”
said Dr. Wadhwa. “I am excited to work with such a passionate team
that genuinely understands the intersection of healthcare and
technology, and the potential we have to change the way people
think about and access healthcare.”
About BioTelemetry
BioTelemetry, Inc. is the leading remote medical technology
company focused on delivery of health information to improve
quality of life and reduce cost of care. We provide remote
cardiac monitoring, remote blood glucose monitoring, centralized
core laboratory services for clinical trials and original equipment
manufacturing that serves both healthcare and clinical research
customers. More information can be found
at www.gobio.com.
Contact:
BioTelemetry, Inc.Heather C. GetzInvestor RelationsExecutive Vice
President, Chief Financial
Officer800-908-7103investorrelations@biotelinc.com
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jul 2023 to Jul 2024